Bacterial Infections
Researchers from University of Milan Report Details of New Studies and Findings in the Area of Bacterial Infections
Published in Vaccine Weekly, March 21st, 2012
2012 MAR 21 -- A new study, "Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists," is now available. According to the authors of a study from Milano, Italy, "Early recognition of invading bacteria by the innate immune system has a crucial function in antibacterial defense by triggering inflammatory responses that prevent the spread of infection and suppress bacterial growth. Toll-like receptor 4 (TLR4), the innate immunity receptor of bacterial endotoxins, plays a pivotal role in the induction of inflammatory responses."
"TLR4 activation by bacterial lipopolysaccharide (LPS) is achieved by the coordinate and sequential...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2012-03-21)
More Articles from Vaccine Weekly
- Hepatitis B Virus
Researchers at Harbin Medical University Release New Data on Hepatitis B Virus - Alzheimer Vaccines
Researchers at Institute for Cancer Research and Treatment (IRCCS) Target Alzheimer Vaccines - Vaccines
Researchers at Open University Have Published New Data on Vaccines - Hepatitis B Virus
Researchers at Suez Canal University Target Hepatitis B Virus - Allergies
Researchers from Complutense University Detail New Studies and Findings in the Area of Allergies - Vaccines
Researchers from GlaxoSmithKline Describe Findings in Vaccines - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
